Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Webcast ImageWebcast
Charles River Laboratories International, Inc. at the Evercore ISI HealthConX Conference (Replay)
11/29/18 at 11:00 a.m. ET

Corporate Profile

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.


News Releases

DateTitle 
11/27/18Charles River Laboratories to Present at Evercore ISI Investor ConferencePrinter Friendly Version
11/13/18Charles River Laboratories Continues Commitment to Oncology Drug DiscoveryPrinter Friendly Version
11/07/18Charles River Laboratories Announces Third-Quarter 2018 ResultsPrinter Friendly Version
10/30/18Charles River to Present Collaborative Methods at Neuroscience 2018Printer Friendly Version
View More

Upcoming Events

There are currently no events scheduled.
View More

Stock Quote

CRL (common)
Price
$120.01
Change (%)
- 0.24 (0.20%)
Volume
242,191
Exchange
NYSE
Data as of 12/18/18 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)